Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients
X‐linked lymphoproliferative disease 1 (XLP1) is an inherited immunodeficiency, caused by mutations in SH2D1A encoding Signaling Lymphocyte Activation Molecule (SLAM)‐associated protein (SAP). In XLP1, 2B4, upon engagement with CD48, has inhibitory instead of activating function. This causes a selec...
Gespeichert in:
Veröffentlicht in: | European journal of immunology 2017-06, Vol.47 (6), p.1051-1061 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1061 |
---|---|
container_issue | 6 |
container_start_page | 1051 |
container_title | European journal of immunology |
container_volume | 47 |
creator | Meazza, Raffaella Falco, Michela Marcenaro, Stefania Loiacono, Fabrizio Canevali, Paolo Bellora, Francesca Tuberosa, Claudia Locatelli, Franco Micalizzi, Concetta Moretta, Alessandro Mingari, Maria C. Moretta, Lorenzo Aricò, Maurizio Bottino, Cristina Pende, Daniela |
description | X‐linked lymphoproliferative disease 1 (XLP1) is an inherited immunodeficiency, caused by mutations in SH2D1A encoding Signaling Lymphocyte Activation Molecule (SLAM)‐associated protein (SAP). In XLP1, 2B4, upon engagement with CD48, has inhibitory instead of activating function. This causes a selective inability of cytotoxic effectors to kill EBV‐infected cells, with dramatic clinical sequelae. Here, we investigated the NK cell education in XLP1, upon characterization of killer Ig‐like receptor (KIR)/KIR‐L genotype and phenotypic repertoire of self‐HLA class I specific inhibitory NK receptors (self‐iNKRs). We also analyzed NK‐cell cytotoxicity against CD48+ or CD48− KIR‐ligand matched or autologous hematopoietic cells in XLP1 patients and healthy controls. XLP1 NK cells may show a defective phenotypic repertoire with substantial proportion of cells lacking self‐iNKR. These NK cells are cytotoxic and the inhibitory 2B4/CD48 pathway plays a major role to prevent killing of CD48+ EBV‐transformed B cells and M1 macrophages. Importantly, self‐iNKR defective NK cells kill CD48− targets, such as mature DCs. Self‐iNKR− NK cells in XLP1 patients are functional even in resting conditions, suggesting a role of the inhibitory 2B4/CD48 pathway in the education process during NK‐cell maturation. Killing of autologous mature DC by self‐iNKR defective XLP1 NK cells may impair adaptive responses, further exacerbating the patients’ immune defect.
In X‐linked lymphoproliferative disease 1 patients, the well‐represented self‐iNKR defective NK cells achieve functional competence through inhibitory 2B4 education. The 2B4/CD48 inhibitory pathway plays a major role in blocking lysis of CD48+ cells, impairing EBV infection resolution. Moreover, NK‐mediated killing of autologous mature dendritic cells (CD48−) can contribute to adaptive immunity dysfunction. |
doi_str_mv | 10.1002/eji.201646885 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1885938943</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1907192282</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4034-db6bb86a204e1f0ea59afbbf7054a2bbee4173ce642cebc2301dfd3e0abc6a6d3</originalsourceid><addsrcrecordid>eNp90M9rFDEYxvEgFrtWj14l4MXL1Dc_JpsctVRdXdoeFLyFJPNOzTKTrMkMsv-9s2ztwYOnQPjw8PIl5BWDSwbA3-EuXnJgSiqt2ydkxVrOGskke0pWAEw23Gg4J89r3QGAUa15Rs65FloZ0CtiN-ln9HHK5UD5B0lDTlOJfp6w0inTm6804DBQ7ObgppgTdamjcRznlId8H4MbaIfFpXscMU2VxkR_bO8Y3S_6-PGCnPVuqPjy4b0g3z9ef7v63GxvP22u3m-bIEHIpvPKe60cB4msB3Stcb33_Rpa6bj3iJKtRUAleUAfuADW9Z1AcD4opzpxQd6edvcl_5qxTnaM9Xi6S5jnatlSxwhtpFjom3_oLs8lLddZZmDNDOeaL6o5qVByrQV7uy9xdOVgGdhjebuUt4_lF__6YXX2I3aP-m_qBfAT-B0HPPx_zV5_2QgjpfgD5ZuOgA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1907192282</pqid></control><display><type>article</type><title>Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients</title><source>MEDLINE</source><source>Wiley Online Library</source><source>Wiley Free Archive</source><source>EZB Electronic Journals Library</source><creator>Meazza, Raffaella ; Falco, Michela ; Marcenaro, Stefania ; Loiacono, Fabrizio ; Canevali, Paolo ; Bellora, Francesca ; Tuberosa, Claudia ; Locatelli, Franco ; Micalizzi, Concetta ; Moretta, Alessandro ; Mingari, Maria C. ; Moretta, Lorenzo ; Aricò, Maurizio ; Bottino, Cristina ; Pende, Daniela</creator><creatorcontrib>Meazza, Raffaella ; Falco, Michela ; Marcenaro, Stefania ; Loiacono, Fabrizio ; Canevali, Paolo ; Bellora, Francesca ; Tuberosa, Claudia ; Locatelli, Franco ; Micalizzi, Concetta ; Moretta, Alessandro ; Mingari, Maria C. ; Moretta, Lorenzo ; Aricò, Maurizio ; Bottino, Cristina ; Pende, Daniela</creatorcontrib><description>X‐linked lymphoproliferative disease 1 (XLP1) is an inherited immunodeficiency, caused by mutations in SH2D1A encoding Signaling Lymphocyte Activation Molecule (SLAM)‐associated protein (SAP). In XLP1, 2B4, upon engagement with CD48, has inhibitory instead of activating function. This causes a selective inability of cytotoxic effectors to kill EBV‐infected cells, with dramatic clinical sequelae. Here, we investigated the NK cell education in XLP1, upon characterization of killer Ig‐like receptor (KIR)/KIR‐L genotype and phenotypic repertoire of self‐HLA class I specific inhibitory NK receptors (self‐iNKRs). We also analyzed NK‐cell cytotoxicity against CD48+ or CD48− KIR‐ligand matched or autologous hematopoietic cells in XLP1 patients and healthy controls. XLP1 NK cells may show a defective phenotypic repertoire with substantial proportion of cells lacking self‐iNKR. These NK cells are cytotoxic and the inhibitory 2B4/CD48 pathway plays a major role to prevent killing of CD48+ EBV‐transformed B cells and M1 macrophages. Importantly, self‐iNKR defective NK cells kill CD48− targets, such as mature DCs. Self‐iNKR− NK cells in XLP1 patients are functional even in resting conditions, suggesting a role of the inhibitory 2B4/CD48 pathway in the education process during NK‐cell maturation. Killing of autologous mature DC by self‐iNKR defective XLP1 NK cells may impair adaptive responses, further exacerbating the patients’ immune defect.
In X‐linked lymphoproliferative disease 1 patients, the well‐represented self‐iNKR defective NK cells achieve functional competence through inhibitory 2B4 education. The 2B4/CD48 inhibitory pathway plays a major role in blocking lysis of CD48+ cells, impairing EBV infection resolution. Moreover, NK‐mediated killing of autologous mature dendritic cells (CD48−) can contribute to adaptive immunity dysfunction.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/eji.201646885</identifier><identifier>PMID: 28386908</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>2B4 ; CD150 antigen ; CD48 ; CD48 Antigen - immunology ; CD48 Antigen - metabolism ; Cell activation ; Complications ; Cytotoxicity ; Genes, MHC Class I ; Histocompatibility antigen HLA ; HLA class I ; Humans ; Immunodeficiency ; Immunoglobulins ; Immunology ; Killer cell immunoglobulin-like receptors ; Killer Cells, Natural - immunology ; Killer Cells, Natural - metabolism ; KIR ; Lymphocyte Activation ; Lymphocyte receptors ; Lymphocytes B ; Lymphoproliferative Disorders - immunology ; Lymphoproliferative Disorders - physiopathology ; Macrophages ; Natural killer cells ; NK cells ; NK receptors ; NK‐cell education ; Potassium Channels, Inwardly Rectifying - immunology ; Receptors, Immunologic - metabolism ; Receptors, Natural Killer Cell - immunology ; SAP ; SAP protein ; SH2D1A protein ; Signal Transduction ; Signaling Lymphocytic Activation Molecule Associated Protein - metabolism ; Signaling Lymphocytic Activation Molecule Family - immunology ; Signaling Lymphocytic Activation Molecule Family - metabolism ; SLAM ; XLP1</subject><ispartof>European journal of immunology, 2017-06, Vol.47 (6), p.1051-1061</ispartof><rights>2017 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4034-db6bb86a204e1f0ea59afbbf7054a2bbee4173ce642cebc2301dfd3e0abc6a6d3</citedby><cites>FETCH-LOGICAL-c4034-db6bb86a204e1f0ea59afbbf7054a2bbee4173ce642cebc2301dfd3e0abc6a6d3</cites><orcidid>0000-0003-1565-451X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Feji.201646885$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Feji.201646885$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,1432,27923,27924,45573,45574,46408,46832</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28386908$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meazza, Raffaella</creatorcontrib><creatorcontrib>Falco, Michela</creatorcontrib><creatorcontrib>Marcenaro, Stefania</creatorcontrib><creatorcontrib>Loiacono, Fabrizio</creatorcontrib><creatorcontrib>Canevali, Paolo</creatorcontrib><creatorcontrib>Bellora, Francesca</creatorcontrib><creatorcontrib>Tuberosa, Claudia</creatorcontrib><creatorcontrib>Locatelli, Franco</creatorcontrib><creatorcontrib>Micalizzi, Concetta</creatorcontrib><creatorcontrib>Moretta, Alessandro</creatorcontrib><creatorcontrib>Mingari, Maria C.</creatorcontrib><creatorcontrib>Moretta, Lorenzo</creatorcontrib><creatorcontrib>Aricò, Maurizio</creatorcontrib><creatorcontrib>Bottino, Cristina</creatorcontrib><creatorcontrib>Pende, Daniela</creatorcontrib><title>Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>X‐linked lymphoproliferative disease 1 (XLP1) is an inherited immunodeficiency, caused by mutations in SH2D1A encoding Signaling Lymphocyte Activation Molecule (SLAM)‐associated protein (SAP). In XLP1, 2B4, upon engagement with CD48, has inhibitory instead of activating function. This causes a selective inability of cytotoxic effectors to kill EBV‐infected cells, with dramatic clinical sequelae. Here, we investigated the NK cell education in XLP1, upon characterization of killer Ig‐like receptor (KIR)/KIR‐L genotype and phenotypic repertoire of self‐HLA class I specific inhibitory NK receptors (self‐iNKRs). We also analyzed NK‐cell cytotoxicity against CD48+ or CD48− KIR‐ligand matched or autologous hematopoietic cells in XLP1 patients and healthy controls. XLP1 NK cells may show a defective phenotypic repertoire with substantial proportion of cells lacking self‐iNKR. These NK cells are cytotoxic and the inhibitory 2B4/CD48 pathway plays a major role to prevent killing of CD48+ EBV‐transformed B cells and M1 macrophages. Importantly, self‐iNKR defective NK cells kill CD48− targets, such as mature DCs. Self‐iNKR− NK cells in XLP1 patients are functional even in resting conditions, suggesting a role of the inhibitory 2B4/CD48 pathway in the education process during NK‐cell maturation. Killing of autologous mature DC by self‐iNKR defective XLP1 NK cells may impair adaptive responses, further exacerbating the patients’ immune defect.
In X‐linked lymphoproliferative disease 1 patients, the well‐represented self‐iNKR defective NK cells achieve functional competence through inhibitory 2B4 education. The 2B4/CD48 inhibitory pathway plays a major role in blocking lysis of CD48+ cells, impairing EBV infection resolution. Moreover, NK‐mediated killing of autologous mature dendritic cells (CD48−) can contribute to adaptive immunity dysfunction.</description><subject>2B4</subject><subject>CD150 antigen</subject><subject>CD48</subject><subject>CD48 Antigen - immunology</subject><subject>CD48 Antigen - metabolism</subject><subject>Cell activation</subject><subject>Complications</subject><subject>Cytotoxicity</subject><subject>Genes, MHC Class I</subject><subject>Histocompatibility antigen HLA</subject><subject>HLA class I</subject><subject>Humans</subject><subject>Immunodeficiency</subject><subject>Immunoglobulins</subject><subject>Immunology</subject><subject>Killer cell immunoglobulin-like receptors</subject><subject>Killer Cells, Natural - immunology</subject><subject>Killer Cells, Natural - metabolism</subject><subject>KIR</subject><subject>Lymphocyte Activation</subject><subject>Lymphocyte receptors</subject><subject>Lymphocytes B</subject><subject>Lymphoproliferative Disorders - immunology</subject><subject>Lymphoproliferative Disorders - physiopathology</subject><subject>Macrophages</subject><subject>Natural killer cells</subject><subject>NK cells</subject><subject>NK receptors</subject><subject>NK‐cell education</subject><subject>Potassium Channels, Inwardly Rectifying - immunology</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Receptors, Natural Killer Cell - immunology</subject><subject>SAP</subject><subject>SAP protein</subject><subject>SH2D1A protein</subject><subject>Signal Transduction</subject><subject>Signaling Lymphocytic Activation Molecule Associated Protein - metabolism</subject><subject>Signaling Lymphocytic Activation Molecule Family - immunology</subject><subject>Signaling Lymphocytic Activation Molecule Family - metabolism</subject><subject>SLAM</subject><subject>XLP1</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90M9rFDEYxvEgFrtWj14l4MXL1Dc_JpsctVRdXdoeFLyFJPNOzTKTrMkMsv-9s2ztwYOnQPjw8PIl5BWDSwbA3-EuXnJgSiqt2ydkxVrOGskke0pWAEw23Gg4J89r3QGAUa15Rs65FloZ0CtiN-ln9HHK5UD5B0lDTlOJfp6w0inTm6804DBQ7ObgppgTdamjcRznlId8H4MbaIfFpXscMU2VxkR_bO8Y3S_6-PGCnPVuqPjy4b0g3z9ef7v63GxvP22u3m-bIEHIpvPKe60cB4msB3Stcb33_Rpa6bj3iJKtRUAleUAfuADW9Z1AcD4opzpxQd6edvcl_5qxTnaM9Xi6S5jnatlSxwhtpFjom3_oLs8lLddZZmDNDOeaL6o5qVByrQV7uy9xdOVgGdhjebuUt4_lF__6YXX2I3aP-m_qBfAT-B0HPPx_zV5_2QgjpfgD5ZuOgA</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Meazza, Raffaella</creator><creator>Falco, Michela</creator><creator>Marcenaro, Stefania</creator><creator>Loiacono, Fabrizio</creator><creator>Canevali, Paolo</creator><creator>Bellora, Francesca</creator><creator>Tuberosa, Claudia</creator><creator>Locatelli, Franco</creator><creator>Micalizzi, Concetta</creator><creator>Moretta, Alessandro</creator><creator>Mingari, Maria C.</creator><creator>Moretta, Lorenzo</creator><creator>Aricò, Maurizio</creator><creator>Bottino, Cristina</creator><creator>Pende, Daniela</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1565-451X</orcidid></search><sort><creationdate>201706</creationdate><title>Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients</title><author>Meazza, Raffaella ; Falco, Michela ; Marcenaro, Stefania ; Loiacono, Fabrizio ; Canevali, Paolo ; Bellora, Francesca ; Tuberosa, Claudia ; Locatelli, Franco ; Micalizzi, Concetta ; Moretta, Alessandro ; Mingari, Maria C. ; Moretta, Lorenzo ; Aricò, Maurizio ; Bottino, Cristina ; Pende, Daniela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4034-db6bb86a204e1f0ea59afbbf7054a2bbee4173ce642cebc2301dfd3e0abc6a6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>2B4</topic><topic>CD150 antigen</topic><topic>CD48</topic><topic>CD48 Antigen - immunology</topic><topic>CD48 Antigen - metabolism</topic><topic>Cell activation</topic><topic>Complications</topic><topic>Cytotoxicity</topic><topic>Genes, MHC Class I</topic><topic>Histocompatibility antigen HLA</topic><topic>HLA class I</topic><topic>Humans</topic><topic>Immunodeficiency</topic><topic>Immunoglobulins</topic><topic>Immunology</topic><topic>Killer cell immunoglobulin-like receptors</topic><topic>Killer Cells, Natural - immunology</topic><topic>Killer Cells, Natural - metabolism</topic><topic>KIR</topic><topic>Lymphocyte Activation</topic><topic>Lymphocyte receptors</topic><topic>Lymphocytes B</topic><topic>Lymphoproliferative Disorders - immunology</topic><topic>Lymphoproliferative Disorders - physiopathology</topic><topic>Macrophages</topic><topic>Natural killer cells</topic><topic>NK cells</topic><topic>NK receptors</topic><topic>NK‐cell education</topic><topic>Potassium Channels, Inwardly Rectifying - immunology</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Receptors, Natural Killer Cell - immunology</topic><topic>SAP</topic><topic>SAP protein</topic><topic>SH2D1A protein</topic><topic>Signal Transduction</topic><topic>Signaling Lymphocytic Activation Molecule Associated Protein - metabolism</topic><topic>Signaling Lymphocytic Activation Molecule Family - immunology</topic><topic>Signaling Lymphocytic Activation Molecule Family - metabolism</topic><topic>SLAM</topic><topic>XLP1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Meazza, Raffaella</creatorcontrib><creatorcontrib>Falco, Michela</creatorcontrib><creatorcontrib>Marcenaro, Stefania</creatorcontrib><creatorcontrib>Loiacono, Fabrizio</creatorcontrib><creatorcontrib>Canevali, Paolo</creatorcontrib><creatorcontrib>Bellora, Francesca</creatorcontrib><creatorcontrib>Tuberosa, Claudia</creatorcontrib><creatorcontrib>Locatelli, Franco</creatorcontrib><creatorcontrib>Micalizzi, Concetta</creatorcontrib><creatorcontrib>Moretta, Alessandro</creatorcontrib><creatorcontrib>Mingari, Maria C.</creatorcontrib><creatorcontrib>Moretta, Lorenzo</creatorcontrib><creatorcontrib>Aricò, Maurizio</creatorcontrib><creatorcontrib>Bottino, Cristina</creatorcontrib><creatorcontrib>Pende, Daniela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meazza, Raffaella</au><au>Falco, Michela</au><au>Marcenaro, Stefania</au><au>Loiacono, Fabrizio</au><au>Canevali, Paolo</au><au>Bellora, Francesca</au><au>Tuberosa, Claudia</au><au>Locatelli, Franco</au><au>Micalizzi, Concetta</au><au>Moretta, Alessandro</au><au>Mingari, Maria C.</au><au>Moretta, Lorenzo</au><au>Aricò, Maurizio</au><au>Bottino, Cristina</au><au>Pende, Daniela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2017-06</date><risdate>2017</risdate><volume>47</volume><issue>6</issue><spage>1051</spage><epage>1061</epage><pages>1051-1061</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><abstract>X‐linked lymphoproliferative disease 1 (XLP1) is an inherited immunodeficiency, caused by mutations in SH2D1A encoding Signaling Lymphocyte Activation Molecule (SLAM)‐associated protein (SAP). In XLP1, 2B4, upon engagement with CD48, has inhibitory instead of activating function. This causes a selective inability of cytotoxic effectors to kill EBV‐infected cells, with dramatic clinical sequelae. Here, we investigated the NK cell education in XLP1, upon characterization of killer Ig‐like receptor (KIR)/KIR‐L genotype and phenotypic repertoire of self‐HLA class I specific inhibitory NK receptors (self‐iNKRs). We also analyzed NK‐cell cytotoxicity against CD48+ or CD48− KIR‐ligand matched or autologous hematopoietic cells in XLP1 patients and healthy controls. XLP1 NK cells may show a defective phenotypic repertoire with substantial proportion of cells lacking self‐iNKR. These NK cells are cytotoxic and the inhibitory 2B4/CD48 pathway plays a major role to prevent killing of CD48+ EBV‐transformed B cells and M1 macrophages. Importantly, self‐iNKR defective NK cells kill CD48− targets, such as mature DCs. Self‐iNKR− NK cells in XLP1 patients are functional even in resting conditions, suggesting a role of the inhibitory 2B4/CD48 pathway in the education process during NK‐cell maturation. Killing of autologous mature DC by self‐iNKR defective XLP1 NK cells may impair adaptive responses, further exacerbating the patients’ immune defect.
In X‐linked lymphoproliferative disease 1 patients, the well‐represented self‐iNKR defective NK cells achieve functional competence through inhibitory 2B4 education. The 2B4/CD48 inhibitory pathway plays a major role in blocking lysis of CD48+ cells, impairing EBV infection resolution. Moreover, NK‐mediated killing of autologous mature dendritic cells (CD48−) can contribute to adaptive immunity dysfunction.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28386908</pmid><doi>10.1002/eji.201646885</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-1565-451X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2980 |
ispartof | European journal of immunology, 2017-06, Vol.47 (6), p.1051-1061 |
issn | 0014-2980 1521-4141 |
language | eng |
recordid | cdi_proquest_miscellaneous_1885938943 |
source | MEDLINE; Wiley Online Library; Wiley Free Archive; EZB Electronic Journals Library |
subjects | 2B4 CD150 antigen CD48 CD48 Antigen - immunology CD48 Antigen - metabolism Cell activation Complications Cytotoxicity Genes, MHC Class I Histocompatibility antigen HLA HLA class I Humans Immunodeficiency Immunoglobulins Immunology Killer cell immunoglobulin-like receptors Killer Cells, Natural - immunology Killer Cells, Natural - metabolism KIR Lymphocyte Activation Lymphocyte receptors Lymphocytes B Lymphoproliferative Disorders - immunology Lymphoproliferative Disorders - physiopathology Macrophages Natural killer cells NK cells NK receptors NK‐cell education Potassium Channels, Inwardly Rectifying - immunology Receptors, Immunologic - metabolism Receptors, Natural Killer Cell - immunology SAP SAP protein SH2D1A protein Signal Transduction Signaling Lymphocytic Activation Molecule Associated Protein - metabolism Signaling Lymphocytic Activation Molecule Family - immunology Signaling Lymphocytic Activation Molecule Family - metabolism SLAM XLP1 |
title | Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T18%3A19%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitory%202B4%20contributes%20to%20NK%20cell%20education%20and%20immunological%20derangements%20in%20XLP1%20patients&rft.jtitle=European%20journal%20of%20immunology&rft.au=Meazza,%20Raffaella&rft.date=2017-06&rft.volume=47&rft.issue=6&rft.spage=1051&rft.epage=1061&rft.pages=1051-1061&rft.issn=0014-2980&rft.eissn=1521-4141&rft_id=info:doi/10.1002/eji.201646885&rft_dat=%3Cproquest_cross%3E1907192282%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1907192282&rft_id=info:pmid/28386908&rfr_iscdi=true |